NCT03304327 ((MYTAC)) is a NA clinical trial of Mindfulness and Yoga Training in Concussion, sponsored by Duke University.

Who is sponsoring NCT03304327?

NCT03304327 is sponsored by Duke University.

What drugs are being tested in NCT03304327?

Interventions in NCT03304327: Mindfulness and Yoga Training.

What condition does NCT03304327 study?

NCT03304327 studies Concussion.

Is NCT03304327 still recruiting?

NCT03304327 is currently completed. Last updated 26 March 2020.

Last reviewed 2020-03-26 · How we verify

NCT03304327: (MYTAC)

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mindfulness and Yoga Training for Athletes With Concussion (MYTAC)

Completed NA Last updated 26 March 2020

What this trial tests

NA trial testing Mindfulness and Yoga Training in Concussion in 16 participants. Completed in 23 September 2019.

Timeline

27 September 2017

Primary endpoint
23 September 2019

23 September 2019

Quick facts

Lead sponsor	Duke University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	16
Start date	27 September 2017
Primary completion	23 September 2019
Estimated completion	23 September 2019
Sites	1 location across United States

Drugs / interventions tested

Mindfulness and Yoga Training

Conditions studied

Concussion — all drugs for Concussion →

Sponsor

Duke University

Who can join

Adults 15 to 60, any sex, with Concussion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to establish the tolerability of mindfulness and yoga therapy in the post-concussion period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Concussion

Currently open trials in the same condition.

NCT05426967 — rTMS for Military TBI-related Depression · NA · recruiting
NCT03710109 — Evaluation of an EEG Based Concussion System · recruiting
NCT03233646 — Retinal Imaging in Neurodegenerative Disease · recruiting

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03304327 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 26 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03304327.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing